Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

about

The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.

P2860

Q52679182-900D1D02-65CD-4120-B863-6C1051FD34B8

P2860

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

Item

http://www.wikidata.org/entity/Q47282493

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@en

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@nl

type

Item

label

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@en

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@nl

prefLabel

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@en

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@nl

P1476

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

@en

P2093

Marcus Vinicius Sadi

http://www.w3.org/2001/XMLSchema#string

Paula Intasqui

http://www.w3.org/2001/XMLSchema#string

Ricardo P Bertolla

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

The human plasma proteome: history, character, and diagnostic prospects

Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression

Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells

An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis

Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease

Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data

Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer

Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.

P304

65-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14789450.2018.1417846

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29251021

http://www.w3.org/2001/XMLSchema#string

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

about

P2860

P2860

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698